AU2001252459A1 - Methods and compositions for effecting homologous recombination - Google Patents

Methods and compositions for effecting homologous recombination

Info

Publication number
AU2001252459A1
AU2001252459A1 AU2001252459A AU5245901A AU2001252459A1 AU 2001252459 A1 AU2001252459 A1 AU 2001252459A1 AU 2001252459 A AU2001252459 A AU 2001252459A AU 5245901 A AU5245901 A AU 5245901A AU 2001252459 A1 AU2001252459 A1 AU 2001252459A1
Authority
AU
Australia
Prior art keywords
compositions
methods
homologous recombination
effecting homologous
effecting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001252459A
Inventor
Elodie Biet
Marie Dutreix
Jean Paul Feugeas
Rosalie Maurisse
Jian-Sheng Sun
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Institut National de la Sante et de la Recherche Medicale INSERM
Institut Curie
Museum National dHistoire Naturelle
Original Assignee
Centre National de la Recherche Scientifique CNRS
Institut National de la Sante et de la Recherche Medicale INSERM
Institut Curie
Museum National dHistoire Naturelle
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS, Institut National de la Sante et de la Recherche Medicale INSERM, Institut Curie, Museum National dHistoire Naturelle filed Critical Centre National de la Recherche Scientifique CNRS
Publication of AU2001252459A1 publication Critical patent/AU2001252459A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102—Mutagenizing nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination

Landscapes

  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001252459A 2000-05-03 2001-05-03 Methods and compositions for effecting homologous recombination Abandoned AU2001252459A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00401218 2000-05-03
EP00401218A EP1152058A1 (en) 2000-05-03 2000-05-03 Methods and compositions for effecting homologous recombination
PCT/IB2001/000749 WO2001083735A1 (en) 2000-05-03 2001-05-03 Methods and compositions for effecting homologous recombination

Publications (1)

Publication Number Publication Date
AU2001252459A1 true AU2001252459A1 (en) 2001-11-12

Family

ID=8173667

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001252459A Abandoned AU2001252459A1 (en) 2000-05-03 2001-05-03 Methods and compositions for effecting homologous recombination

Country Status (6)

Country Link
US (1) US6936418B2 (en)
EP (2) EP1152058A1 (en)
JP (1) JP2003531610A (en)
AU (1) AU2001252459A1 (en)
CA (1) CA2407900A1 (en)
WO (1) WO2001083735A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6335160B1 (en) * 1995-02-17 2002-01-01 Maxygen, Inc. Methods and compositions for polypeptide engineering
US7582292B2 (en) * 2000-02-26 2009-09-01 Artecel, Inc. Adipose tissue derived stromal cells for the treatment of neurological disorders
SG134168A1 (en) * 2000-02-26 2007-08-29 Artecel Sciences Inc Pleuripotent stem cells generated from adipose tissue-derived stromal cells and uses thereof
GB0218803D0 (en) * 2002-08-13 2002-09-18 Nl Kanker I Targeted gene modification by single-standed DNA oligonucleotides
WO2007073149A1 (en) * 2005-12-22 2007-06-28 Keygene N.V. Alternative nucleotides for improved targeted nucleotide exchange
EP2756845B1 (en) * 2009-04-03 2017-03-15 Dicerna Pharmaceuticals, Inc. Methods and compositions for the specific inhibition of KRAS by asymmetric double-stranded RNA
US10260089B2 (en) 2012-10-29 2019-04-16 The Research Foundation Of The State University Of New York Compositions and methods for recognition of RNA using triple helical peptide nucleic acids
NZ712727A (en) 2013-03-14 2017-05-26 Caribou Biosciences Inc Compositions and methods of nucleic acid-targeting nucleic acids
KR102304487B1 (en) * 2013-03-15 2021-09-24 시버스 유에스 엘엘씨 Targeted gene modification using oligonucleotide-mediated gene repair
AU2015308910B2 (en) * 2014-08-27 2017-12-07 Caribou Biosciences, Inc. Methods for increasing Cas9-mediated engineering efficiency
EP3344771A4 (en) 2015-08-31 2019-03-20 Agilent Technologies, Inc. Compounds and methods for crispr/cas-based genome editing by homologous recombination
EP3868880A1 (en) * 2016-04-29 2021-08-25 Basf Plant Science Company GmbH Improved methods for modification of target nucleic acids

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5849482A (en) * 1988-09-28 1998-12-15 Epoch Pharmaceuticals, Inc. Crosslinking oligonucleotides
HU218095B (en) * 1990-05-01 2000-05-28 Amgen Inc. Process for reducing transitional contaminations in amplification processes
AU6328696A (en) * 1995-06-07 1996-12-30 Yale University Treatment of hemoglobinopathies
US5776744A (en) * 1995-06-07 1998-07-07 Yale University Methods and compositions for effecting homologous recombination
JP2809601B2 (en) * 1995-07-13 1998-10-15 株式会社分子バイオホトニクス研究所 Base sequence amplification method
JP2002522096A (en) * 1998-08-12 2002-07-23 パンジーン・コーポレイション Development of domain-specific genes

Also Published As

Publication number Publication date
US6936418B2 (en) 2005-08-30
CA2407900A1 (en) 2001-11-08
EP1152058A1 (en) 2001-11-07
JP2003531610A (en) 2003-10-28
EP1278832A1 (en) 2003-01-29
WO2001083735A1 (en) 2001-11-08
US20030003547A1 (en) 2003-01-02

Similar Documents

Publication Publication Date Title
AUPQ419099A0 (en) Novel compositions and methods
AU2778801A (en) Antisense compositions and methods
AU2002357119A1 (en) Mitocidal compositions and methods
AU2001245660A1 (en) Embolic compositions
AU2001280604A1 (en) Compositions comprising icariside i and anhydroicaritin and methods for making the same
AU2001292783A1 (en) Antireflective composition
AU2002246666A1 (en) Anti-icing composition
AUPQ875700A0 (en) Combination compositions
AU6618900A (en) Compositions useful as desiccants and methods relating thereto
AU2001252459A1 (en) Methods and compositions for effecting homologous recombination
AU2002357748A1 (en) Osteopontin-related compositions and methods
AU2001241098A1 (en) Composition
AU2002221129A1 (en) Triglyceride depressant composition
AU2681500A (en) Rapidly-soluble compositions
AU2002210433A1 (en) Dental compositions
AU2001233932A1 (en) Method and composition
AU5085300A (en) Compositions
AU1799801A (en) Homologous recombination in plants
AU4784900A (en) Polyolefin compositions using natural compound as antioxidant and/or heat-resistant
AU2001287852A1 (en) Composition
AU2001261317A1 (en) Immunostimulant compositions and associated methods
AU2001235764A1 (en) Compositions
AU2001223721A1 (en) Dental compositions
AU2001287732A1 (en) Copolycarbonate-based composition
AU2001234685A1 (en) Methods and compositions for enhancing formyltetrahydropteroylpolyglutamate in plants